Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting
− Data presented from the pivotal Phase 3 trial include an update on overall efficacy of the vaccine candidate, as well as...